Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

Clinical trial NCT05536297 · COMPLETED

Trial details

NCT number: NCT05536297
Sponsor: Astellas Pharma Global Development, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Geographic Atrophy Age-Related Macular Degeneration

Start date: 2022-09-26
Primary completion: 2025-04-10
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.